Isonics Corporation (NASDAQ: ISOND), a provider of innovative solutions for the homeland security and semiconductor markets, announced that it has received notification from the Nasdaq Hearings department that it has regained compliance with the market price requirements for continued listing on the Nasdaq Capital Market. The hearing originally scheduled for March 1, 2007, with the Nasdaq Hearings department has been cancelled. On January 12, 2007, Isonics announced that it received a staff determination letter from the Nasdaq Stock Market Listings Qualification Department notifying the Company that its common stock was not in compliance with the $1.00 per share minimum bid price requirement for continued inclusion under Nasdaq Marketplace Rule 4310(c)(4) and was subject to delisting from the Nasdaq Capital Market. Because the Company�s common stock has closed above $1.00 for 10 consecutive trading days, the Company has regained compliance with the minimum bid price requirement for continued listing. The Company will continue to be subject to other continued listing requirements, including a requirement for either a minimum level of stockholders� equity or market value of listed securities, and can offer no assurances that it will be able to sustain compliance with all continued listing requirements. About Isonics Corporation Isonics Corporation has three business divisions: (1) Homeland Security and Defense (2) Semiconductor Products and Services, and (3) Life Sciences (which is currently in the process of being divested). Isonics is a world leader in isotopically engineered materials and through its semiconductor division, it provides 300-millimeter products and services, wafer thinning and silicon-on-insulator wafers, for the semiconductor industry. Isonics' Life Sciences division markets and sells isotopes to the health care industry for the imaging and treatment of cancer. Stable isotopes can be thought of as ultra pure materials. This high degree of purification provides enhanced properties as compared to natural materials. Additional information may be obtained at the Company's Web site at www.isonics.com. Cautionary Statement Except for historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve estimates, assumptions, known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Further, the Company operates in industries where securities values may be volatile and may be influenced by regulatory and other factors beyond the Company's control. Other important factors that the Company believes might cause such differences are discussed in the risk factors detailed in the Company's 10-KSB for the year ended April 30, 2006 and reports subsequently filed with the Securities and Exchange Commission, which include the Company's historical cash flow difficulties, dependence on significant customers, and rapid development of technology, among other risks. In assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements contained in these filings with the Securities and Exchange Commission.
Isonics (MM) (NASDAQ:ISOND)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Isonics  (MM) Charts.
Isonics (MM) (NASDAQ:ISOND)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Isonics  (MM) Charts.